BIOHARVEST SCIENCES INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
SEC Category
Emerging growth company
State of Incorporation
British Columbia, Canada
Business Address
1140 - 625 HOWE STREET, VANCOUVER, A1, V6C 2T6
Mailing Address
1140 - 625 HOWE STREET, VANCOUVER, A1, V6C 2T6
Phone
6046221186
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025 FY
$34.51M
Revenue
-$11.13M
Net Income
$25.45M
Stockholders' Equity
$23.02M
Cash & Equivalents
$-0.60
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 40-F Canadian company annual report | March 31, 2026 | View on SEC |
| 6-K Foreign company current report | March 27, 2026 | View on SEC |
| 6-K Foreign company current report | March 17, 2026 | View on SEC |
| 6-K Foreign company current report | March 16, 2026 | View on SEC |
| 6-K Foreign company current report | March 6, 2026 | View on SEC |
| 6-K Foreign company current report | March 5, 2026 | View on SEC |
| 6-K Foreign company current report | March 3, 2026 | View on SEC |
| 6-K Foreign company current report | January 7, 2026 | View on SEC |
| 6-K Foreign company current report | December 18, 2025 | View on SEC |
| 6-K Foreign company current report | December 3, 2025 | View on SEC |
Annual Reports
40-F
March 31, 2026
- Successfully listed on the NASDAQ (ticker: BHST) in November 2024.
- Clinical trials confirmed VINIA® improves insulin sensitivity and reduces HbA1c levels.
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN
Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB
Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA
Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.